Allarity Therapeutics Revamps Finance Strategy and Leadership
Company Announcements

Allarity Therapeutics Revamps Finance Strategy and Leadership

Allarity Therapeutics, Inc. ( (ALLR) ) just unveiled an announcement.

Allarity Therapeutics, Inc. has updated its financing strategy by amending an agreement to potentially sell up to $50 million in common stock through Ascendiant Capital Markets, LLC. Simultaneously, the company announced a key executive change, appointing Alexander Epshinsky as the new CFO after Joan Y. Brown’s departure. Epshinsky brings extensive experience in finance, previously serving in high-level accounting roles at several biotech firms. His employment agreement includes a competitive salary, bonus potential, equity incentives, and severance terms. With these changes, Allarity Therapeutics is poised to explore various financing opportunities to support its growth and strategic objectives.

Find detailed analytics on ALLR stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAllarity granted EPO for DRP companion diagnostic for stenoparib
TheFlyAllarity regains compliance with NASDAQ minimum bid price requirement
Austin AngeloALLR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App